Completed
Multicenter Unsustained Tachycardia Trial (MUSTT)
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2017-01-16
N/A
Participants Needed
N/A
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine the value of electrophysiologic (EP)-guided antiarrhythmic therapy in coronary heart disease patients at increased risk for sudden death. The study included a controlled clinical trial and a registry.
CONDITIONS
Official Title
Multicenter Unsustained Tachycardia Trial (MUSTT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
Men and women patients with documented coronary artery disease, ejection fraction less than or equal to 40 percent, and nonsustained asymptomatic ventricular tachycardia.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here